Janssen Pharmaceutica, NV v. Apotex, Inc.

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

• describing Hatch- Waxman Act provisions creating potential 180-day period of exclusivity as incentive for first generic manufacturer to file ANDA
• “We agree with the parties that if Apotex had not stipulated to the validity of the '663 patent, then Caraco would have been controlling.”
• “We agree with the parties that if Apotex had not stipulated to the validity of the '663 patent, then Caraco would have been controlling.”
• “The 180[-]day exclusivity period is important to generic pharmaceutical companies as it promotes patent challenges by enabling a generic company a period to recover its investment in these challenges.”

Source: CourtListener parenthetical corpus (CC0).